Andrew Ashe

Andrew Ashe

President en VERVE THERAPEUTICS, INC. .

Fortuna: 4 M $ al 31/03/2024

57 años
Health Technology
Commercial Services
Consumer Services

Perfil

Andrew D.
Ashe
is currently the President, COO & General Counsel at Verve Therapeutics, Inc. Prior to his current position, he held the role of General Counsel at Beacon Therapeutics (USA), Inc. from 2017 to 2018.
Before that, he served as Secretary, Executive VP & General Counsel at Dyax Corp.
from 2015 to 2016.
Additionally, Mr. Ashe was a Member-Business Law Practices at Nutter McClennen & Fish LLP and Prince Lobel Tye LLP.
He obtained his undergraduate degree from the University of Massachusetts and his graduate degree from George Washington University Law School.
He also holds an undergraduate degree from The Isenberg School of Management.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
14/02/2024 266 509 ( 0.34% ) 4 M $ 31/03/2024

Cargos activos de Andrew Ashe

Antiguos cargos conocidos de Andrew Ashe.

EmpresasCargoFin
APPLIED GENETIC TECHNOLOGIES CORPORATION General Counsel 01/08/2018
DYAX CORP. Chief Administrative Officer 01/01/2016
Corporate Officer/Principal -
Corporate Officer/Principal -
Ver el detalle de la experiencia de Andrew Ashe.

Formación de Andrew Ashe.

The Isenberg School of Management Undergraduate Degree
George Washington University Law School Graduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Andrew Ashe.

Relaciones

59

Relaciones de 1er grado

7

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas1
VERVE THERAPEUTICS, INC.

Health Technology

Empresas privadas4

Health Technology

Commercial Services

Health Technology

Commercial Services

Ver las conexiones de la empresa